Join to view full profile
1500 E. Duarte RdDuarte, CA 91010
Phone+1 626-471-9200
Fax+1 626-301-8233
Dr. Chao is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Joseph Chao is an oncologist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 13 years. He specializes in gastrointestinal cancers with a research focus in stomach and esophageal cancers.
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2007 - 2010- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2004 - 2007
University of Illinois College of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2006 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2013-2017
- CMS Meaningful Use Stage 2 Certification Sunrise Acute Care, Allscripts, 2013-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2017
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery
- Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer Start of enrollment: 2014 Jun 11
Publications & Presentations
PubMed
- Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.Michael S Lee, Joseph Chao, Mary F Mulcahy, Pashtoon M Kasi, Angela T Alistar
The Oncologist. 2025-07-04 - 155 citationsCAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.Kim A Reiss, Mathew G Angelos, E Claire Dees, Yuan Yuan, Naoto T Ueno
Nature Medicine. 2025-04-01 - 4 citationsA Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.Andrew H Ko, Joseph Chao, Marcus S Noel, Veena Shankaran, Davendra Sohal
Cancer Research Communications. 2025-02-01
Press Mentions
Pembro for Gastric Cancers: High Microsatellite Instability May Be Key to Good ResponsesApril 6th, 2021- Bringing Personalized Medicine to Precision Medicine in Gastroesophageal CancerFebruary 5th, 2020
City of Hope Scientists Are Using Combination Immunotherapy to Treat Advanced CancersApril 8th, 2019
Committees
- Gastroesophageal Medical Oncology Co-Chair, Via Oncology Pathways Disease Committee 2017 - Present
- Panel Member, NCCN Gastric Cancer Guidelines 2014 - Present
- Panel Member, NCCN Esophageal and Esophagogastric Junction Cancers 2014 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
